文献速递安宁疗护老年慢病共病管理

长期护理机构临终症状缓解药物处方率的回顾性队列研究

Palliative End-of-Life Medication Prescribing Rates in Long-Term Care: A Retrospective Cohort Study.
PubMed 文献 · J Am Med Dir Assoc · 2024-01-17

该研究基于加拿大安大略省626家公立长期护理机构的行政健康数据,回顾性分析了55,916例在2017年1月1日至2020年3月17日期间死亡的居民。研究测量了每家机构在居民生命最后14天内至少开具一种皮下临终症状管理药物的死者比例,并按处方率将机构分为五分位。结果显示平均64.7%的死者接受了至少一种此类药物,阿片类药物最常用(平均62.7%),且处方率最低五分位与最高五分位差异显著(37.3% vs 82.5%),同时低处方率机构有更高比例的居民在14天内转出(30.3% vs 12.7%)。

要点

  • 长期护理机构中约三分之二的死者在生命最后两周接受了至少一种皮下临终症状管理药物。
  • 不同机构间临终药物处方率差异大,最低五分位平均37.3%,最高五分位平均82.5%。
  • 处方率最低的机构中居民转出比例更高(30.3% vs 12.7%)。

核心结论

  • 安大略省长期护理机构间皮下临终症状缓解药物处方率存在巨大差异,行政数据可用于洞察临终照护的系统性提供。

研究设计与样本

  • 回顾性队列研究,使用行政健康数据,纳入加拿大安大略省所有626家公立长期护理机构中2017年1月1日至2020年3月17日期间的55,916例死者。

主要发现

  • 平均64.7%的长期护理死者在生命最后14天内被开具至少一种皮下临终症状管理药物。
  • 阿片类药物是最常开具的药物,总体平均处方率为62.7%。
  • 处方率最低五分位机构的平均处方率为37.3%,最高五分位为82.5%。
  • 最低处方率五分位机构中30.3%的居民在14天内转出长期护理,而最高五分位为12.7%。

临床怎么用

  • 临床可参考机构间处方率差异,审视本机构临终症状管理药物的使用情况。
  • 对处方率偏低的机构,可关注是否与居民转出率高相关,并评估临终症状控制是否充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medications are often needed to manage distressing end-of-life symptoms (eg, pain, agitation). OBJECTIVES: In this study, we describe the variation in prescribing rates of symptom relief medications at the end of life among long-term care (LTC) decedents. We evaluate the extent these medications are prescribed in LTC homes and whether prescribing rates of end-of-life symptom management can be used as an indicator of quality end-of-life care. DESIGN: Retrospective cohort study using administrative health data. SETTING AND PARTICIPANTS: LTC decedents in all 626 publicly funded LTC homes in Ontario, Canada, between January 1, 2017, and March 17, 2020. METHODS: For each LTC home, we measured the percent of decedents who received 1+ prescription(s) for a subcutaneous end-of-life symptom management medication ("end-of-life medication") in their last 14 days of life. We then ranked LTC homes into quintiles based on prescribing rates. RESULTS: We identified 55,916 LTC residents who died in LTC. On average, two-thirds of decedents (64.7%) in LTC homes were prescribed at least 1 subcutaneous end-of-life medication in the last 2 weeks of life. Opioids were the most common prescribed medication (overall average prescribing rate of 62.7%). LTC homes in the lowest prescribing quintile had a mean of 37.3% of decedents prescribed an end-of-life medication, and the highest quintile mean was 82.5%. In addition, across these quintiles, the lowest prescribing quintile had a high average (30.3%) of LTC residents transferred out of LTC in the 14 days compared with the highest prescribing quintile (12.7%). CONCLUSIONS AND IMPLICATIONS: Across Ontario's LTC homes, there are large differences in prescribing rates for subcutaneous end-of-life symptom relief medications. Although future work may elucidate why the variability exists, this study provides evidence that administrative data can provide valuable insight into the systemic delivery of end-of-life care.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Tanuseputro P, Roberts RL, Milani C, et al. Palliative End-of-Life Medication Prescribing Rates in Long-Term Care: A Retrospective Cohort Study. J Am Med Dir Assoc. 2024. PMID: 38242534. doi:10.1016/j.jamda.2023.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。